ACCELERON PHARMA INC Insider Trading for July 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for July 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 25 2016 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 32.98 | 20,000 | 659,600 | 20,000 | |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.28 | 6,000 | 31,680 | 1,896 | |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.28 | 6,000 | 31,680 | 79,604 | 73.6 K to 79.6 K (+8.15 %) |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 4,421 | 23,343 | 1,883 | |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 4,421 | 23,343 | 131,577 | 127.2 K to 131.6 K (+3.48 %) |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 16,251 | |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 62,600 | 57.6 K to 62.6 K (+8.68 %) |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 1.80 | 95,000 | 171,000 | 0 | |
| Jul 07 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 1.80 | 95,000 | 171,000 | 214,084 | 119.1 K to 214.1 K (+79.78 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.28 | 4,604 | 24,309 | 7,896 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 3.88 | 3,500 | 13,580 | 0 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.08 | 5,896 | 29,952 | 0 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 34.89 | 20,207 | 705,022 | 73,604 | 93.8 K to 73.6 K (-21.54 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 34.20 | 5,793 | 198,121 | 93,811 | 99.6 K to 93.8 K (-5.82 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.28 | 4,604 | 24,309 | 99,604 | 95 K to 99.6 K (+4.85 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 3.88 | 3,500 | 13,580 | 95,000 | 91.5 K to 95 K (+3.83 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.08 | 5,896 | 29,952 | 91,500 | 85.6 K to 91.5 K (+6.89 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 3,966 | 20,940 | 6,304 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 18,095 | 95,542 | 10,270 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 3.88 | 10,209 | 39,611 | 0 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 34.13 | 500 | 17,065 | 127,156 | 127.7 K to 127.2 K (-0.39 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 32.89 | 3,466 | 113,997 | 127,656 | 131.1 K to 127.7 K (-2.64 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 3,966 | 20,940 | 131,122 | 127.2 K to 131.1 K (+3.12 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 34.77 | 28,304 | 984,130 | 127,156 | 155.5 K to 127.2 K (-18.21 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 18,095 | 95,542 | 155,460 | 137.4 K to 155.5 K (+13.17 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 3.88 | 10,209 | 39,611 | 137,365 | 127.2 K to 137.4 K (+8.03 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 5.28 | 15,300 | 80,784 | 9,400 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 34.66 | 25,300 | 876,898 | 57,600 | 82.9 K to 57.6 K (-30.52 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 5.28 | 15,300 | 80,784 | 82,900 | 67.6 K to 82.9 K (+22.63 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 41,477 | 218,999 | 42,500 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 30,501 | 161,045 | 83,977 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.28 | 23,022 | 121,556 | 114,478 | |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.26 | 10,437 | 357,572 | 119,084 | 129.5 K to 119.1 K (-8.06 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.58 | 31,040 | 1,042,323 | 129,521 | 160.6 K to 129.5 K (-19.33 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 41,477 | 218,999 | 160,561 | 119.1 K to 160.6 K (+34.83 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.22 | 2,390 | 81,786 | 119,084 | 121.5 K to 119.1 K (-1.97 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 33.18 | 28,111 | 932,723 | 121,474 | 149.6 K to 121.5 K (-18.79 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 30,501 | 161,045 | 149,585 | 119.1 K to 149.6 K (+25.61 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.92 | 20,626 | 720,260 | 119,084 | 139.7 K to 119.1 K (-14.76 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 34.18 | 7,396 | 252,795 | 139,710 | 147.1 K to 139.7 K (-5.03 %) |
| Jul 06 2016 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.28 | 23,022 | 121,556 | 147,106 | 124.1 K to 147.1 K (+18.55 %) |